- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.05. | Sona Nanotech Inc: Sona completes toxicity study on its gold nanorods | 14 | Stockwatch | ||
| 27.05. | Sona Nanotech Inc.: Sona Successfully Completes FDA-Required Toxicity Study | 399 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - May 27, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce positive results from a required preclinical safety... ► Artikel lesen | |
| SONA NANOTECH Aktie jetzt für 0€ handeln | |||||
| 16.05. | Sona Nanotech Inc: Sona completes bacterial endotoxin test on nanorods | 4 | Stockwatch | ||
| 15.05. | Sona Nanotech Inc.: Sona Announces Successful Study Showing Absence of Endotoxins In Its Cancer Therapy Gold Nanorods Prior to First-in-human Clinical Trial | 676 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - May 15, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce the successful completion of bacterial endotoxin... ► Artikel lesen | |
| 07.05. | BioVaxys & Sona Nanotech Enter Research Collaboration | 3 | Contract Pharma | ||
| 07.05. | Sona Nanotech Inc.: BioVaxys and Sona Nanotech Enter Research Collaboration | 621 | Newsfile | Vancouver, British Columbia, and Halifax, Nova Scotia--(Newsfile Corp. - May 7, 2025) - BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB) (OTCQB: BVAXF) ("BioVaxys") and Sona Nanotech Inc. (CSE: SONA)... ► Artikel lesen | |
| 07.05. | BioVaxys Technology Corp.: BioVaxys and Sona Nanotech Enter Research Collaboration | 826 | PR Newswire | VANCOUVER, BC and HALIFAX, NS, May 7, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and Sona Nanotech Inc.... ► Artikel lesen | |
| 01.05. | Sona Nanotech Inc: Sona Nanotech grants options to buy 2.13 million shares | 1 | Stockwatch | ||
| 01.05. | Sona Nanotech Inc.: Sona Nanotech Announces Annual Options Grants | 1.088 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - May 1, 2025) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona") announces that it has granted 2,135,000 incentive stock options under... ► Artikel lesen | |
| 19.03. | Sona Nanotech Inc.: Sona Presents Additional Preclinical Data Demonstrating Repeated Ability Of Its Cancer Therapy To Inhibit Tumor Growth In Colorectal Cancer Model | 847 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - March 19, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to provide updated data confirming efficacy of its Targeted... ► Artikel lesen | |
| 06.03. | Sona Nanotech Inc. CEO David Regan to Present at the Investor Summit Virtual on March 11 | 478 | ACCESS Newswire | NEW YORK, NY / ACCESS Newswire / March 6, 2025 / David Regan, CEO of Sona Nanotech Inc. (OTCQB:SNANF)(CSE:SONA), will be presenting at this year's Investor Summit Virtual on March 11th at 11:30am ET.About... ► Artikel lesen | |
| 12.02. | Sona Nanotech Inc.: Sona Nanotech's Targeted Hyperthermia Therapy To Be Presented at the International 19th Canadian Melanoma Conference | 471 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - February 12, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that its recently published findings from its... ► Artikel lesen | |
| 14.01. | Sona Nanotech Inc: Sona publishes THT cancer therapy efficacy studies | 1 | Stockwatch | ||
| 13.01. | Sona Nanotech Inc.: Sona Nanotech's THT Cancer Therapy Preclinical Efficacy Studies Published In Peer-Reviewed Scientific Journal | 500 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - January 13, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that the now complete findings from our previously... ► Artikel lesen | |
| 12.12.24 | Sona Nanotech Inc: Sona releases results from preclinical study of GNRs | 4 | Stockwatch | ||
| 11.12.24 | Sona Nanotech Inc.: Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study | 597 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - December 11, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") announces results from its most recent preclinical study of its Targeted... ► Artikel lesen | |
| 07.11.24 | Sona Nanotech Inc.: Sona Nanotech to Showcase Its THT Cancer Therapy at NCL 20th Anniversary Symposium and Provides Corporate Update | 596 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - November 7, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that its Chief Scientific Officer, Dr. Len Pagliaro... ► Artikel lesen | |
| 21.10.24 | Sona Nanotech Inc.: Sona Nanotech Issued Patent and Appoints New Board Member | 578 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 21, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce the issuance of U.S. Patent No. 12117447 by... ► Artikel lesen | |
| 09.10.24 | Sona Nanotech Inc.: Sona Nanotech Grants Options | 586 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - October 9, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that it has granted 25,000 incentive stock... ► Artikel lesen | |
| 24.09.24 | Sona Nanotech Inc.: Sona Nanotech Closes Private Placement Financing to Raise $1,643,750 in Gross Proceeds | 773 | Newsfile | Halifax, Nova Scotia--(Newsfile Corp. - September 24, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that it has closed its non-brokered private... ► Artikel lesen |
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 27,400 | 0,00 % | Kursverluste für die Aktie von Formycon (23,50 €) | Das Wertpapier von Formycon notiert heute leichter. Der jüngste Kurs betrug 23,50 Euro. An der deutschen Börse hat sich heute die Formycon-Aktie zwischenzeitlich um 0,84 Prozent verbilligt. Der Kurs... ► Artikel lesen | |
| OBDUCAT | 0,040 | -11,11 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025 | Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen | |
| SOLESENCE | 3,840 | -2,78 % | SOLESENCE, INC. - 8-K, Current Report | ||
| KOPIN | 1,296 | +0,15 % | Kopin macht Fortschritte bei AR/VR mit neuem NeuralDisplay-Prototyp | ||
| ONTO INNOVATION | 86,00 | +1,78 % | EQS-Media: LPKF Laser & Electronics SE: Onto Innovation und LPKF treiben gemeinsam die Massenproduktion von Glassubstraten für Halbleiter voran | EQS-Media / 02.04.2025 / 09:00 CET/CEST
Onto Innovation und LPKF treiben gemeinsam die Massenproduktion von Glassubstraten für Halbleiter voran
LPKF schließt sich dem Packaging Applications... ► Artikel lesen | |
| GOMSPACE | 1,310 | +4,30 % | GomSpace Group AB: GomSpace reports positive net profit in Q1 2025 | GomSpace releases its Q1 2025 trading statement and reports a strong revenue growth, positive operational EBITDA and a positive net profit in the first quarter.
FIRST QUARTER OF 2025
Order intake... ► Artikel lesen | |
| DOTZ NANO | 0,025 | -3,85 % | DOTZ NANO LIMITED: Cleansing Statement | ||
| FENDX TECHNOLOGIES | 0,044 | -6,44 % | FendX Technologies Inc.: FendX Announces Share Issuance Pursuant to IP License Agreement | Oakville, Ontario--(Newsfile Corp. - May 5, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), a nanotechnology company developing surface protection... ► Artikel lesen | |
| ACACIA RESEARCH | 3,220 | +1,26 % | ACACIA RESEARCH CORP - 8-K, Current Report | ||
| ADVANCE ZINCTEK | 0,428 | -0,47 % | ADVANCE ZINCTEK LIMITED: Business Update | ||
| LEHNER INVESTMENTS | 0,033 | +10,00 % | EQS-Adhoc: LEHNER INVESTMENTS AG: Sonderprüfung gerichtlich angeordnet | EQS-Ad-hoc: LEHNER INVESTMENTS AG / Schlagwort(e): Rechtssache
LEHNER INVESTMENTS AG: Sonderprüfung gerichtlich angeordnet
04.04.2025 / 18:00 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen | |
| NANOFOCUS | 1,400 | 0,00 % | NanoFocus: Hauptaktionär plant Squeeze-out | Die Carl Mahr Holding GmbH hat ein offizielles Verlangen auf Durchführung eines aktienrechtlichen Squeeze-outs bei der NanoFocus AG übermittelt. Demnach soll die Hauptversammlung einen Beschluss fassen... ► Artikel lesen | |
| RIBER | 2,715 | 0,00 % | Riber receives order from Asia for MBE 412 research system | ||
| NANOVIRICIDES | 1,220 | -5,43 % | NanoViricides Measles Drug Development Animal Study is Imminent | SHELTON, CT / ACCESS Newswire / June 4, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum... ► Artikel lesen | |
| REGION GROUP | 1,336 | +0,09 % | Dividendenbekanntmachungen (30.01.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AZZ INC US0024741045 0,17 USD 0,1631 EUR BANK OF MONTREAL CA0636711016 1,59 CAD 1,0581 EUR DAIWA CYCLE CO LTD JP3501950004 37... ► Artikel lesen |
Das Unternehmen SONA NANOTECH INC kann der Branche Nanotechnologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SONA NANOTECH INC finden Sie auf Wallstreet Online.